BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 34439807)

  • 1. The Role of Mesenchymal Stem Cells (MSCs) in Veterinary Medicine and Their Use in Musculoskeletal Disorders.
    Prządka P; Buczak K; Frejlich E; Gąsior L; Suliga K; Kiełbowicz Z
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man.
    de Bakker E; Van Ryssen B; De Schauwer C; Meyer E
    Vet Q; 2013 Dec; 33(4):225-33. PubMed ID: 24404887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries?
    De Schauwer C; Van de Walle GR; Van Soom A; Meyer E
    Vet Q; 2013 Dec; 33(4):234-41. PubMed ID: 23697553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regenerative medicine laboratory: facilitating stem cell therapy for equine disease.
    Borjesson DL; Peroni JF
    Clin Lab Med; 2011 Mar; 31(1):109-23. PubMed ID: 21295725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?
    Mocchi M; Dotti S; Bue MD; Villa R; Bari E; Perteghella S; Torre ML; Grolli S
    Cells; 2020 Jun; 9(6):. PubMed ID: 32545382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse.
    Barrachina L; Romero A; Zaragoza P; Rodellar C; Vázquez FJ
    Vet J; 2018 Aug; 238():49-57. PubMed ID: 30103915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Stem Cells for the Treatment of Musculoskeletal Injuries in Horses.
    Watts AE
    Vet Clin North Am Equine Pract; 2023 Dec; 39(3):475-487. PubMed ID: 37625917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cells from umbilical cord and placenta for musculoskeletal tissue engineering.
    Longo UG; Loppini M; Berton A; La Verde L; Khan WS; Denaro V
    Curr Stem Cell Res Ther; 2012 Jul; 7(4):272-81. PubMed ID: 22563663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose-Derived Mesenchymal Stem Cells: A Promising Tool in the Treatment of Musculoskeletal Diseases.
    Torres-Torrillas M; Rubio M; Damia E; Cuervo B; Del Romero A; Peláez P; Chicharro D; Miguel L; Sopena JJ
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal criteria for reporting mesenchymal stem cells in veterinary regenerative medicine.
    Sharun K; Banu SA; Pawde AM; Dhama K; Pal A
    Vet Res Commun; 2024 Jun; 48(3):1973-1976. PubMed ID: 38671338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells for treatment of musculoskeletal disease in horses: Relative merits of allogeneic versus autologous stem cells.
    Colbath AC; Dow SW; McIlwraith CW; Goodrich LR
    Equine Vet J; 2020 Sep; 52(5):654-663. PubMed ID: 31971273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
    Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
    Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise Review: Mesenchymal Stem Cells: From Roots to Boost.
    Andrzejewska A; Lukomska B; Janowski M
    Stem Cells; 2019 Jul; 37(7):855-864. PubMed ID: 30977255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells in veterinary medicine.
    Fortier LA; Travis AJ
    Stem Cell Res Ther; 2011 Feb; 2(1):9. PubMed ID: 21371354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies.
    Cavallo C; Cuomo C; Fantini S; Ricci F; Tazzari PL; Lucarelli E; Donati D; Facchini A; Lisignoli G; Fornasari PM; Grigolo B; Moroni L
    J Cell Biochem; 2011 May; 112(5):1418-30. PubMed ID: 21321995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs).
    Mazini L; Rochette L; Amine M; Malka G
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31121953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells as therapeutic target of biophysical stimulation for the treatment of musculoskeletal disorders.
    Viganò M; Sansone V; d'Agostino MC; Romeo P; Perucca Orfei C; de Girolamo L
    J Orthop Surg Res; 2016 Dec; 11(1):163. PubMed ID: 27986082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell therapy in equine musculoskeletal disease: scientific fact or clinical fiction?
    Taylor SE; Smith RK; Clegg PD
    Equine Vet J; 2007 Mar; 39(2):172-80. PubMed ID: 17378447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report.
    Renzi S; Riccò S; Dotti S; Sesso L; Grolli S; Cornali M; Carlin S; Patruno M; Cinotti S; Ferrari M
    Res Vet Sci; 2013 Aug; 95(1):272-7. PubMed ID: 23419936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine mesenchymal stem cells from synovium have a higher chondrogenic potential than those from infrapatellar fat pad, adipose tissue, and bone marrow.
    Sasaki A; Mizuno M; Ozeki N; Katano H; Otabe K; Tsuji K; Koga H; Mochizuki M; Sekiya I
    PLoS One; 2018; 13(8):e0202922. PubMed ID: 30138399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.